Skip to main content
SpringerLink
Log in

Breast Cancer in Elderly Women: is Partial Breast Irradiation a Good Alternative?

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Background. Approximately half of all breast cancer occurs after age 65. Several aspects for the treatment of early breast cancer may be influenced by patient age, including postoperative radiation therapy (RT), in order to prevent the risk of local recurrence (LR). Postoperative adjuvant RT, improving the chances of local control, is not always completed because of comorbidity-associated factors. Does an alternative exist between a 5-week radiotherapy regime and no irradiation after breast conservative surgery without burdening the overall therapeutic management?

Methods. The authors review the literature regarding age-specific issues in the irradiation of breast cancer and the potential role of a partial breast irradiation (PBI) to prevent LR in the ipsilateral breast.

Results. Phase II and III trials have been analyzed for feasibility, efficacy and toxicity. PBI may be delivered with low or high dose rate brachytherapy and intra operative, or external beam radiation therapy. PBI satisfies the control quality criteria. The majority of the teams provide PBI recurrence rates lower than 5% (0–4.4%) with a median follow-up varying between 8 and 72 months, associated with cosmetic results comparable to those achieved with conventional external beam.

Conclusions. Breast cancer in elderly women represents a medical and economical problem. The recommended conservative treatment includes RT for 50 Gy over 5 weeks. Some subgroups of patients did not receive radiotherapy because of comorbidity-associated factors or more favorable tumor biology. PBI seems to be an acceptable alternative to adjuvant RT over 5 weeks and no irradiation. The evaluation of toxicity and efficacy, especially in terms of local control, is necessary and large multicentric phase III trials comparing the two irradiation approaches are needed, including quality of life, economic considerations and longer follow-up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. GLOBOCAN 2000: Cancer Incidence, Mortality and PrevalenceWorldwide, Version 1.0. IARC CancerBase No. 5. Lyon, IARCPress, 2001

    Google Scholar 

  2. De Vathaire F, Koscielny S, Rezvani A: Réseau FRANCIM. Statistiques de santé. Estimation de l'incidence des cancers en France 1983-1987. Les éditions INSERM, Paris, 1996

  3. Dinh Quang Chi: La population de la France à l'horizon 2050. Économie et Statistique, INSEE 274: 7–32, 1994

    Google Scholar 

  4. Balducci L, Lyman GH: Cancer in the elderly. Epidemiologic and clinical implications. Clin Geriatr Med 13: 1–14, 1997

    Google Scholar 

  5. Evans JG: Oxford Textbook of Geriatric Medicine. Introduction. 2nd edn, Oxford University Press, Oxford, 2000, pp 1–4

    Google Scholar 

  6. Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM: Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 333: 1456–1461, 1995

    Google Scholar 

  7. Clark RM, Whelan T, Levine M, Roberts R, Willan A, McCulloch P, Lipa M, Wilkinson RH, Mahoney LJ: Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst 88: 1659–1664, 1996

    Google Scholar 

  8. Forrest AP, Stewart HJ, Everington D, Prescott RJ, McArdle CS, Harnett AN, Smith DC, George WD: Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet 348: 708–713, 1996

    Google Scholar 

  9. Liljegren G, Holmberg L, Bergh J, Lindgren A, Tabar L, Nordgren H, Adami HO: 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol 17: 2326–2333, 1999

    Google Scholar 

  10. Veronesi U, Marubini E, Mariani L, Galimberti V, Luini A, Veronesi P, Salvadori B, Zucali R: Radiotherapy after breast-conserving surgery in small breast carcinoma: longterm results of a randomized trial. Ann Oncol 12: 997–1003, 2001

    Google Scholar 

  11. [No authors listed] Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 355: 1757–1770, 2000

  12. Robertson JF, Ellis IO, Elston CW, Blamey RW: Mastectomy or tamoxifen as initial therapy for operable breast cancer in elderly patients: 5-year follow-up. Eur J Cancer 28A: 908–910, 1992

    Google Scholar 

  13. Gazet JC, Ford HT, Coombes RC, Bland JM, Sutcliffe R, Quilliam J, Lowndes S: Prospective randomized trial of tamoxifen v.s. surgery in elderly patients with breast cancer. Eur J Surg Oncol 20: 207–214, 1994

    Google Scholar 

  14. Kantorowitz DA, Poulter CA, Sischy B, Paterson E, Sobel SH, Rubin P, Dvoretsky PA, Mishalak W, Doane KL: Treatment of breast cancer among elderly women with segmental mastectomy or segmental mastectomy plus postoperative radiotherapy. Int J Radiat Oncol Biol Phys 15: 263–270, 1988

    Google Scholar 

  15. Reed MW, Morrison JM: Wide local excision as the sole primary treatment in elderly patients with carcinoma of the breast. Br J Surg 76: 898–900, 1989

    Google Scholar 

  16. Nemoto T, Patel JK, Rosner D, Dao TL, Schuh M, Penetrante R: Factors affecting recurrence in lumpectomy without irradiation for breast cancer. Cancer 67: 2079–2082, 1991

    Google Scholar 

  17. Bates T, Riley DL, Houghton J, Fallowfield L, Baum M: Breast cancer in elderly women: a Cancer Research Campaign trial comparing treatment with tamoxifen and optimal surgery with tamoxifen alone. The Elderly Breast Cancer Working Party. Br J Surg 78: 591–594, 1991

    Google Scholar 

  18. von Rueden DG, Sessions SC: Alternative therapy for elderly patients with breast cancer. Am Surg 60: 72–78, 1994

    Google Scholar 

  19. Cooke AL, Perera F, Fisher B, Opeitum A, Yu N: Tamoxifen with and without radiation after partial mastectomy in patients with involved nodes. Int J Radiat Oncol Biol Phys 31: 777–781, 1995

    Google Scholar 

  20. de Csepel J, Tartter PI, Gajdos C: When not to give radiation therapy after breast conservation surgery for breast cancer. J Surg Oncol 74: 273–277, 2000

    Google Scholar 

  21. Vlastos G, Mirza NQ, Meric F, Hunt KK, Kuerer HM, Ames FC, Ross MI, Buchholz TA, Hortobagyi GN, Singletary SE: Breast conservation therapy as a treatment option for the elderly. The M. D. Anderson experience. Cancer 92: 1092–1100, 2001

    Google Scholar 

  22. Solin LJ, Schultz DJ, Fowble BL: Ten-year results of the treatment of early-stage breast carcinoma in elderly women using breast-conserving surgery and definitive breast irradiation. Int J Radiat Oncol Biol Phys 33: 45–51, 1995

    Google Scholar 

  23. Fowble B: An assessment of treatment options for breast conservation in the elderly woman with early stage breast cancer. Int J Radiat Oncol Biol Phys 31: 1015–1017, 1995

    Google Scholar 

  24. Bartelink H, Horiot JC, Poortmans P, Struikmans H, Van den Bogaert W, Barillot I, Fourquet A, Borger J, Jager J, Hoogenraad W, Collette L, Pierart M: European Organization for Research and Treatment of Cancer Radiotherapy and Breast Cancer Groups. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345: 1378–1387, 2001

    Google Scholar 

  25. Ballard-Barbash R, Potosky AL, Harlan LC, Nayfield SG, Kessler LG: Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 88: 716–726, 1996

    Google Scholar 

  26. Hebert-Croteau N, Brisson J, Latreille J, Blanchette C, Deschenes L: Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women. Cancer 85: 1104–1113, 1999

    Google Scholar 

  27. Mandelblatt JS, Hadley J, Kerner JF, Schulman KA, Gold K, Dunmore-Griffith J, Edge S, Guadagnoli E, Lynch JJ, Meropol NJ, Weeks JC, Winn R: Patterns of breast carcinoma treatment in older women: patient preference and clinical and physical influences. Cancer 89: 561–573, 2000

    Google Scholar 

  28. Nattinger AB, Kneusel RT, Hoffmann RG, Gilligan MA: Relationship of distance from a radiotherapy facility and initial breast cancer treatment. J Natl Cancer Inst 93: 1344–1346, 2001

    Google Scholar 

  29. Gruenberger T, Gorlitzer M, Soliman T, Rudas M, Mittlboeck M, Gnant M, Reiner A, Teleky B, Seitz W, Jakesz R: It is possible to omit postoperative irradiation in a highly selected group of elderly breast cancer patients. Breast Cancer Res Treat 50: 37–46, 1998

    Google Scholar 

  30. Benhaim DI, Lopchinsky R, Tartter PI: Lumpectomy with tamoxifen as primary treatment for elderly women with earlystage breast cancer. Am J Surg 180: 162–166, 2000

    Google Scholar 

  31. Diab SG, Elledge RM, Clark GM: Tumor characteristics and clinical outcome of elderly women with breast cancer. J Natl Cancer Inst 92: 550–556, 2000

    Google Scholar 

  32. Hughes KS, Schnaper L, Berry D, Wood C, Henderson C, Norton L: Comparison of lumpectomy plus tamoxifen with and without radiotherapy (RT) in women 70 years of age or older who have clinical stage I, estrogen receptor positive (ER+) breast carcinoma. Proc Am Soc Clin Oncol 20: 24a (abstract 93), 2001

    Google Scholar 

  33. Fyles A, McCready D, Manchul L, Trudeau M, Olivotto I, Merante P, Pintilie M, Weir L: Preliminary results of a randomized study of tamoxifen +/-breast irradiation in T1/2 N0 disease in women over 50 years of age. Proc Am Soc Clin Oncol 20: 24a (abstract 92), 2001

    Google Scholar 

  34. Fisher B, Bryant J, Dignam JJ, Wickerham DL, Mamounas EP, Fisher ER, Margolese RG, Nesbitt L, Paik S, Pisansky TM, Wolmark N: Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 20: 4141–4149, 2002

    Google Scholar 

  35. Silliman RA, Balducci L, Goodwin JS, Holmes FF, Leventhal EA: Breast cancer care in old age: what we know, don't know, and do. J Natl Cancer Inst 85: 190–199, 1993

    Google Scholar 

  36. Balducci L, Extermann M, Carreca I: Management of breast cancer in the older woman. Cancer Control 8: 431–434, 2001

    Google Scholar 

  37. Jewell WR, Krishnan L, Reddy EK, Thomas JH, Mansfield CM: Intraoperative implantation radiation therapy plus lumpectomy for carcinoma of the breast. Arch Surg 122: 687–690, 1987

    Google Scholar 

  38. Cionini L, Pacini P, Marzano S, Distante V, Cardona G, Bianchi S: Exclusive brachytherapy after conservative surgery in cancer of the breast. Lyon Chir 89: 128 (abstract 14), 1993

    Google Scholar 

  39. Fentiman IS, Poole C, Tong D, Winter PJ, Mayles HM, Turner P, Chaudary MA, Rubens RD: Iridium implant treatment without external radiotherapy for operable breast cancer: a pilot study. Eur J Cancer 27: 447–450, 1991

    Google Scholar 

  40. Fentiman IS, Poole C, Tong D, Winter PJ, Gregory WM, Mayles HM, Turner P, Chaudary MA, Rubens RD: Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer 32A: 608–611, 1996

    Google Scholar 

  41. Vicini F, Kini VR, Chen P, Horwitz E, Gustafson G, Benitez P, Edmundson G, Goldstein N, McCarthy K, Martinez A: Irradiation of the tumor bed alone after lumpectomy in selected patients with early-stage breast cancer treated with breast conserving therapy. J Surg Oncol 70: 33–40, 1999

    Google Scholar 

  42. Vicini FA, Baglan KL, Kestin LL, Mitchell C, Chen PY, Frazier RC, Edmundson G, Goldstein NS, Benitez P, Huang RR, Martinez A: Accelerated treatment of breast cancer. J Clin Oncol 19: 1993–2001, 2001

    Google Scholar 

  43. Kuske RR, Bolton JS, Wilenzick RM, McKinnon WMP, Pullen B, Scroggins TG, Zakris EL, Fineberg BB: Brachytherapy as the sole method of breast irradiation in Tis, T1, T2, N0-1 breast cancer. Int J Radiat Oncol Biol Phys 30: 245 (abstract 1004), 1994

    Google Scholar 

  44. King TA, Bolton JS, Kuske RR, Fuhrman GM, Scroggins TG, Jiang XZ: Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg 180: 299–304, 2000

    Google Scholar 

  45. Krishnan L, Jewell WR, Tawfik OW, Krishnan EC: Breast conservation therapy with tumor bed irradiation alone in a selected group of patients with stage I breast cancer. Breast J 7: 91–96, 2001

    Google Scholar 

  46. Perera F, Engel J, Holliday R, Scott L, Girotti M, Girvan D, Chisela F, Venkatesan V: Local resection and brachytherapy confined to the lumpectomy site for early breast cancer: a pilot study. J Surg Oncol 65: 263–267, 1997

    Google Scholar 

  47. Wazer DE, Berle L, Graham R, Chung M, Rothschild J, Graves T, Cady B, Ulin K, Ruthazer R, DiPetrillo TA: Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys 53: 889–897, 2002

    Google Scholar 

  48. Polgar C, Sulyok Z, Fodor J, Orosz Z, Major T, Takacsi-Nagy Z, Mangel LC, Somogyi A, Kasler M, Nemeth G: Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol 80: 121–128, 2002

    Google Scholar 

  49. Ribeiro GG, Magee B, Swindell R, Harris M, Banerjee SS: The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol (R Coll Radiol) 5: 278–283, 1993

    Google Scholar 

  50. Formenti SC, Rosenstein B, Skinner KA, Jozsef G: T1 stage breast cancer: adjuvant hypofractionated conformal radiation therapy to tumor bed in selected postmenopausal breast cancer patients-pilot feasibility study. Radiology 222: 171–178, 2002

    Google Scholar 

  51. Veronesi U, Orecchia R, Luini A, Gatti G, Intra M, Zurrida S, Ivaldi G, Tosi G, Ciocca M, Tosoni A, De Lucia F: A preliminary report of intraoperative radiotherapy (IORT) in limited-stage breast cancers that are conservatively treated. Eur J Cancer 37: 2178–2183, 2001

    Google Scholar 

  52. Dubois JB, Hay M, Gely S, Saint-Aubert B, Rouanet P, Pujol H: IORT in breast carcinomas. Front Radiat Ther Oncol 31: 131–137, 1997

    Google Scholar 

  53. Vaidya JS, Baum M, Tobias JS, D'Souza DP, Naidu SV, Morgan S, Metaxas M, Harte KJ, Sliski AP, Thomson E: Targeted intra-operative radiotherapy (Targit): an innovative method of treatment for early breast cancer. Ann Oncol 12: 1075–1080, 2001

    Google Scholar 

  54. Nag S: The evolving role of brachytherapy in breast cancer. Am J Clin Oncol 18: 353–357, 1995

    Google Scholar 

  55. White JR, Wilson JF: Brachytherapy and breast cancer. Semin Surg Oncol 13: 190–195, 1997

    Google Scholar 

  56. Buchholz TA, Austin-Seymour MM, Moe RE, Ellis GK, Livingston RB, Pelton JG, Griffin TW: Effect of delay in radiation in the combined modality treatment of breast cancer. Int J Radiat Oncol Biol Phys 26: 23–35, 1993

    Google Scholar 

  57. Leonard CE, Wood ME, Zhen B, Rankin J, Waitz DA, Norton L, Howell K, Sedlacek S: Does administration of chemotherapy before radiotherapy in breast cancer patients treated with conservative surgery negatively impact local control? J Clin Oncol 13: 2906–2615, 1995

    Google Scholar 

  58. Hebert-Croteau N, Freeman CR, Latreille J, Brisson J: Delay in adjuvant radiation treatment and outcomes of breast cancer-a review. Breast Cancer Res Treat 74: 77–94, 2002

    Google Scholar 

  59. Wazer DE, Lowther D, Boyle T, Ulin K, Neuschatz A, Ruthazer R, DiPetrillo TA: Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer. Int J Radiat Oncol Biol Phys 50: 107–111, 2001

    Google Scholar 

  60. Boyages J, Bilous M, Barraclough B, Langlands AO: Fat necrosis of the breast following lumpectomy and radiation therapy for early breast cancer. Radiother Oncol 13: 69–74, 1988

    Google Scholar 

  61. Edmundson GK, Vicini FA, Chen PY, Mitchell C, Martinez AA: Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator. Int J Radiat Oncol Biol Phys 52: 1132–1139, 2002

    Google Scholar 

  62. Keisch M, Vicini F, Kuske RR, Hebert M, White J, Quiet C, Arthur D, Scroggins T, Streeter O: Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breastconserving therapy. Int J Radiat Oncol Biol Phys 55: 289–293, 2003

    Google Scholar 

  63. Dutreix J, Cosset JM, Girinsky T: Biological equivalency of high single doses used in intraoperative irradiation. Bull Cancer Radiother 77: 125–134, 1990

    Google Scholar 

  64. Kimmick GG, Balducci L: Breast cancer and aging. Clinical interactions. Hematol Oncol Clin North Am 14: 213–234, 2000

    Google Scholar 

  65. Yancik R, Ries LA: Aging and cancer in America. Demographic and epidemiologic perspectives. Hematol Oncol Clin North Am 14: 17–23, 2000

    Google Scholar 

  66. Rosen PP, Fracchia AA, Urban JA, Schottenfeld D, Robbins GF: ‘Residual’ mammary carcinoma following simulated partial mastectomy. Cancer 35: 739–747, 1975

    Google Scholar 

  67. Holland R, Connolly JL, Gelman R, Mravunac M, Hendriks JH, Verbeek AL, Schnitt SJ, Silver B, Boyages J, Harris JR: The presence of an extensive intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 8: 113–118, 1990

    Google Scholar 

  68. Fisher ER, Sass R, Fisher B, Gregorio R, Brown R, Wickerham L: Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). II. Relation of local breast recurrence to multicentricity. Cancer 57: 1717–1724, 1986

    Google Scholar 

  69. Fowble B, Solin LJ, Schultz DJ, Rubenstein J, Goodman RL: Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. Int J Radiat Oncol Biol Phys 19: 833–842, 1990

    Google Scholar 

  70. Veronesi U, Salvadori B, Luini A, Banfi A, Zucali R, Del Vecchio M, Saccozzi R, Beretta E, Boracchi P, Farante G: Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy. Ann Surg 211: 250–259, 1990

    Google Scholar 

  71. Liljegren G, Holmberg L, Adami HO, Westman G, Graffman S, Bergh J: Sector resection with or without postoperative radiotherapy for stage I breast cancer: five-year results of a randomized trial. Uppsala-Orebro Breast Cancer Study Group. J Natl Cancer Inst 86: 717–722, 1994

    Google Scholar 

  72. Vaidya JS, Vyas JJ, Chinoy RF, Merchant N, Sharma OP, Mittra I: Multicentricity of breast cancer: whole-organ analysis and clinical implications. Br J Cancer 74: 820–824, 1996

    Google Scholar 

  73. Smith TE, Lee D, Turner BC, Carter D, Haffty BG: True recurrence v.s. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses and therapeutic management. Int J Radiat Oncol Biol Phys 48: 1281–1289, 2000

    Google Scholar 

  74. Dewar JA, Arriagada R, Benhamou S, Benhamou E, Bretel JJ, Pellae-Cosset B, Marin JL, Petit JY, Contesso G, Sarrazin D: Local relapse and contralateral tumor rates in patients with breast cancer treated with conservative surgery and radiotherapy (Institut Gustave Roussy 1970-1982). IGR Breast Cancer Group. Cancer 76: 2260–2265, 1995

    Google Scholar 

  75. Broet P, de la Rochefordiere A, Scholl SM, Fourquet A, Mosseri V, Durand JC, Pouillart P, Asselain B: Contralateral breast cancer: metastasis or second primary cancer? Bull Cancer 83: 870–876, 1996

    Google Scholar 

  76. Abdalla I, Thisted RA, Heimann R: The impact of contralateral breast cancer on the outcome of breast cancer patients treated by mastectomy. Cancer J 6: 266–272, 2000

    Google Scholar 

  77. Obedian E, Fischer DB, Haffty BG: Second malignancies after treatment of early-stage breast cancer: lumpectomy and radiation therapy versus mastectomy. J Clin Oncol 18: 2406–2412, 2000

    Google Scholar 

  78. Fowble B, Hanlon A, Freedman G, Nicolaou N, Anderson P: Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk. Int J Radiat Oncol Biol Phys 51: 679–690, 2001

    Google Scholar 

  79. Galper S, Gelman R, Recht A, Silver B, Kohli A, Wong JS, Van Buren T, Baldini EH, Harris JR: Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer. Int J Radiat Oncol Biol Phys 52: 406–414, 2002

    Google Scholar 

  80. Deore SM, Sarin R, Dinshaw KA, Shrivastava SK: Influence of dose-rate and dose per fraction on clinical outcome of breast cancer treated by external beam irradiation plus iridium-192 implants: analysis of 289 cases. Int J Radiat Oncol Biol Phys 26: 601–606, 1993

    Google Scholar 

  81. Hill C: We should change the conduct of clinical trials in oncology. Bull Cancer 89: 823–825, 2002

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Center Antoine Lacassagne, Nice, Italy

    J.M. Hannoun-Levi, A. Courdi & J.P. Gerard

  2. Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France

    H. Marsiglia

  3. Brachytherapy Unit, Radiation Oncology Department, European Institute of Oncology, Milan, Italy

    H. Marsiglia

  4. Department of Medical Oncology, Center Antoine Lacassagne, Nice, Italy

    M. Namer

Authors
  1. J.M. Hannoun-Levi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Courdi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Marsiglia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Namer
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J.P. Gerard
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hannoun-Levi, J., Courdi, A., Marsiglia, H. et al. Breast Cancer in Elderly Women: is Partial Breast Irradiation a Good Alternative?. Breast Cancer Res Treat 81, 243–251 (2003). https://doi.org/10.1023/A:1026166518203

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026166518203

Search

Navigation